Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
Seferović PM, Polovina M, Bauersachs J, Arad M, Ben Gal T, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimović R, Miličić D, Milinković I, Noutsias M, Oto A, Oto Ö, Pavlović SU, Piepoli MF, Ristić AD, Rosano GMC, Seggewiss H, Ašanin M, Seferović JP, Ruschitzka F, Čelutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschöpe C. Seferović PM, et al. Among authors: farmakis d. Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16. Eur J Heart Fail. 2019. PMID: 30989768 Free article.
Levosimendan for the treatment of acute heart failure syndromes.
Parissis JT, Filippatos G, Farmakis D, Adamopoulos S, Paraskevaidis I, Kremastinos D. Parissis JT, et al. Among authors: farmakis d. Expert Opin Pharmacother. 2005 Dec;6(15):2741-51. doi: 10.1517/14656566.6.15.2741. Expert Opin Pharmacother. 2005. PMID: 16316312 Review.
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT. Adamopoulos S, et al. Among authors: farmakis d. Am J Cardiol. 2006 Jul 1;98(1):102-6. doi: 10.1016/j.amjcard.2006.01.068. Epub 2006 May 6. Am J Cardiol. 2006. PMID: 16784930 Clinical Trial.
Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT. Parissis JT, et al. Among authors: farmakis d. Heart. 2006 Dec;92(12):1768-72. doi: 10.1136/hrt.2006.079707. Heart. 2006. PMID: 17105880 Free PMC article. Clinical Trial.
Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients.
Aessopos A, Farmakis D, Polonifi A, Tsironi M, Fragodimitri C, Hatziliami A, Karagiorga M, Diamanti-Kandarakis E. Aessopos A, et al. Among authors: farmakis d. Eur J Heart Fail. 2007 May;9(5):537-41. doi: 10.1016/j.ejheart.2006.12.004. Epub 2007 Feb 14. Eur J Heart Fail. 2007. PMID: 17300987 Free article.
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.
Parissis JT, Karavidas A, Bistola V, Arapi S, Paraskevaidis IA, Farmakis D, Korres D, Filippatos G, Matsakas E, Kremastinos DT. Parissis JT, et al. Among authors: farmakis d. Atherosclerosis. 2008 Mar;197(1):278-82. doi: 10.1016/j.atherosclerosis.2007.04.023. Epub 2007 Jun 12. Atherosclerosis. 2008. PMID: 17568589 Clinical Trial.
303 results